http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27754639

Outgoing Links

Predicate Object
contentType Journal Article|Review
issn 0753-3322
pageRange 109732-
publicationName Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
startingPage 109732
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_da423cdd7db342c5cf98238a332743af
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_70abf1ffb7b93a873efff855532f08ab
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3d3ad8cfc22ff5cd29fbdc7d4498f760
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation Adelusi TI, Du L, Hao M, Zhou X, Xuan Q, Apu C, Sun Y, Lu Q, Yin X. Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy. Biomed Pharmacother. 2020 Mar;123():109732. doi: 10.1016/j.biopha.2019.109732. PMID: 31945695.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98f8bafffde5cd6445cfaa88680aa836
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86dc714b0ba27d2c16b1544a84aa0c74
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad225c65c34958f3c3e6d1061ece471e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f9aa58d22d7be38b06b1a9871a49a5b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5130810a9ec500adfecd41d0058c7d2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9abbcd131c2a684a1c26ee12a35bfaa9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0777023c79c04944441f26c02d62c54
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7509b27a26b30df7f705ffaf3099635
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65e533627e382d24797d456b7896b711
date 202003
identifier https://doi.org/10.1016/j.biopha.2019.109732
https://pubmed.ncbi.nlm.nih.gov/31945695
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1156
https://portal.issn.org/resource/ISSN/0753-3322
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy
discusses http://id.nlm.nih.gov/mesh/M0444138
http://id.nlm.nih.gov/mesh/M0237441
http://id.nlm.nih.gov/mesh/M000616243
http://id.nlm.nih.gov/mesh/M0479977
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D003928Q000378
http://id.nlm.nih.gov/mesh/D061745Q000502
http://id.nlm.nih.gov/mesh/D015398Q000187
http://id.nlm.nih.gov/mesh/D003928Q000188
http://id.nlm.nih.gov/mesh/D051267Q000378
http://id.nlm.nih.gov/mesh/D000072019Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D061745Q000235
http://id.nlm.nih.gov/mesh/D051267Q000235
http://id.nlm.nih.gov/mesh/D010084
http://id.nlm.nih.gov/mesh/D000072019Q000235
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7447
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f56a221bc770a5fa884ac7d3634f29a8
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8072
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8d8efb5335a904318b9014eccec9d3e9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_35183e58044cead667c478e29ea1e7b2
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10868

Total number of triples: 51.